About Nick Seaver
Nick Seaver is chief financial and business officer and a director of ai3Bio. He is also a managing director at Ziff Capital Partners, where he focuses on direct private investments in biotech. He is chief financial and business officer of Corner Therapeutics, a Ziff Capital Partners-backed company developing cancer vaccines. He sits on the board of the MED13L Foundation, which works to find treatments for the rare condition MED13L.
Earlier in his career, Seaver worked in private equity at JP Morgan Partners and was chief executive officer of Thanyapura, a diversified holding company.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Nick Seaver in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Nick Seaver works with at each company, as listed on that company's latest Form D.
